Jiaxin Wang

Jiaxin Wang

Auto-generated profile, based on publicly available information

Jiaxin Wang

Chinese Academy of Medical Sciences and Peking Union Medical College

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JWJiaxin Wang
Jiaxin Wang
SYShujuan Yang
Shujuan Yang
XMXuan Ma
Xuan Ma
KZKankan Zhao
Kankan Zhao
KYKai Yang
Kai Yang
SZShihua Zhao
Shihua Zhao
Identifying patients with hypertrophic cardiomyopathy (HCM) who are candidates for implantable cardioverter defibrillator (ICD) implantation in primary prevention for sudden cardiac death (SCD) is crucial. The aim of this study was to externally validate the 2022 European Society of Cardiology (ESC) model and other guideline-based ICD class of recommendation (ICD-COR) models and explore the utility of late gadolinium enhancement (LGE) in further risk stratification. Seven hundred and seventy-four consecutive patients who underwent cardiac magnetic resonance imaging were retrospectively enrolled. Forty-six (5.9%) patients reached the SCD-related endpoint during 7.4 ± 2.5 years of follow-up. Patients suffering from SCD had higher ESC Risk-SCD score (4.3 ± 2.4% vs. 2.8 ± 2.1%, P < .001) and LGE extent (13.7 ± 9.4% vs. 4.9 ± 6.6%, P < .001). Compared with the 2014 ESC model, the 2022 ESC model showed increased area under the curve (.76 vs. .63), sensitivity (76.1% vs. 43.5%), positive predictive value (16.8% vs. 13.6%), and negative predictive value (98.1% vs. 95.9%). The C-statistics for SCD prediction of 2011 American College of Cardiology (ACC)/American Heart Association (AHA), 2014 ESC, 2020 AHA/ACC, and 2022 ESC models were .68, .64, .76 and .78, respectively. Furthermore, in patients without extensive LGE, LGE ≥5% was responsible for seven-fold SCD risk after multivariable adjustment. Whether in ICD-COR II or ICD-COR III, patients with LGE ≥5% and <15% showed significantly worse prognosis than those with LGE <5% (all P < .001). The 2022 ESC model performed better than the 2014 ESC model with especially improved sensitivity. LGE enabled further risk stratification based on current guidelines. In a sizable Chinese cohort of 774 patients with hypertrophic cardiomyopathy, 46 (5.9%) patients suffered SCD events during a mean follow-up of 7.4 years. The new 2022 ESC model performed better than 2014 ESC model for SCD risk stratification with increased C-statistics from 0.64 to 0.78 and especially improved sensitivity from 43.5% to 76.1%. 2022 ESC model and 2020 AHA/ACC model showed similar overall discrimination performance. LGE with a cut-off of 5% enabled further risk stratification based on current 2022 ESC and 2020 AHA/ACC guidelines.

2 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZDZhixiang Dong
Zhixiang Dong
XMXuan Ma
Xuan Ma
JWJiaxin Wang
Jiaxin Wang
SYShujuan Yang
Shujuan Yang
SYShiqin Yu
Shiqin Yu
SZShihua Zhao
Shihua Zhao
Background: Strain analysis is a sensitive method for the assessment of ventricular structural or functional alterations. The authors aimed to determine whether right ventricular (RV) strain parameters can discriminate patients with revised Task Force Criteria–diagnosed arrhythmogenic RV cardiomyopathy (ARVC) incremental to the existing cardiovascular magnetic resonance (CMR) criteria, thus improving the diagnostic yield of CMR in ARVC. Methods and Results: A total of 74 patients with revised Task Force Criteria–diagnosed ARVC (37 borderline and 37 definite) and 37 controls were retrospectively enrolled for analysis. Using CMR feature tracking, RV global longitudinal (GLS), circumferential, and radial strain of all participants were evaluated. Compared with controls, the study patients demonstrated significantly impaired global biventricular strain in all 3 directions (all P 50% presenting with impaired RV GLS. When both conventional criteria and RV GLS were considered together, this new diagnostic method demonstrated an overall diagnostic accuracy of 90%. The likelihood ratio test showed a significant incremental diagnostic value of RV GLS ( P =0.02) over the existing CMR major criteria. Conclusions: The current study showed an improved diagnostic accuracy when both RV GLS and the existing CMR criteria were considered together, especially for patients with borderline diagnosis, suggesting the incremental value of strain analysis to the initial assessment of ARVC.

6 July 2022 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
ZDZhixiang Dong
Zhixiang Dong
GYGang Yin
Gang Yin
KYKai Yang
Kai Yang
KJKe Jiang
Ke Jiang
ZWZhigang Wu
Zhigang Wu
SZShihua Zhao
Shihua Zhao
This study aims to validate and compare the feasibility of T1ρ and native longitudinal relaxation time (T1) mapping in detection of myocardial fibrosis in patients with non-ischaemic cardiomyopathy, focusing on the performance of both methods in identifying late gadolinium enhancement (LGE) grey zone. Twenty-seven hypertrophic cardiomyopathy (HCM) patients, 16 idiopathic dilated cardiomyopathy (DCM) patients, and 18 healthy controls were prospectively enrolled for native T1 and T1ρ mapping imaging and then all the patients underwent enhancement scan for LGE extent and extracellular volume (ECV) values. In LGE positive patients, the LGE areas were divided into LGE core (6 SDs above remote myocardium) and grey zone (2–6 SDs above remote myocardium) according to the signal intensity of LGE. Both HCM and DCM patients showed significantly higher native T1 values and T1ρ values than controls no matter the presence of LGE (all P < 0.01). There were significant differences in native T1 and T1ρ values among four different types of myocardia (LGE core, grey zone, remote area and control, P < 0.0001). However, the T1ρ values of grey zone were significantly higher than control (P < 0.01), while the native T1 values were not (P = 0.089). T1ρ values were significantly associated with both native T1 values (r = 0.54, P < 0.001) and ECV values (r = 0.54, P < 0.001). T1ρ mapping is a feasible method to detect myocardial fibrosis in patients with non-ischaemic cardiomyopathy no matter the presence of LGE. Compared with native T1, T1ρ may serve as a better discriminator in the identification of LGE grey zone.

1 June 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
ZDZhixiang Dong
Zhixiang Dong
LDLinlin Dai
Linlin Dai
YSYanyan Song
Yanyan Song
XMXuan Ma
Xuan Ma
JWJiaxin Wang
Jiaxin Wang
SZShihua Zhao
Shihua Zhao
Right ventricular global longitudinal strain derived from cardiac MRI feature tracking demonstrated good diagnostic and prognostic value in arrhythmogenic right ventricular cardiomyopathy. Purpose To demonstrate the myocardial strain characteristics of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), based on revised Task Force Criteria (rTFC), and to explore the...

1 February 2025 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
ZDZhixiang Dong
Zhixiang Dong
YTYun Tang
Yun Tang
PSPeng Sun
Peng Sun
GYGang Yin
Gang Yin
KZKankan Zhao
Kankan Zhao
SZShihua Zhao
Shihua Zhao
In hypertrophic cardiomyopathy, myocardial microstructural alterations could be detected by in vivo cardiac diffusion-tensor imaging even before the appearance of cardiac MRI findings of hypertrophy or fibrosis.

11 February 2025 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PZPengyu Zhou
Pengyu Zhou
ZDZhixiang Dong
Zhixiang Dong
XHXiaoying Hu
Xiaoying Hu
SYShujuan Yang
Shujuan Yang
JWJiaxin Wang
Jiaxin Wang
SZShihua Zhao
Shihua Zhao
Aims: This study aimed to evaluate the association between cardiac magnetic resonance imaging (CMR) multiparameters and significant acute cardiac allograft rejection (SR), and assess the incremental value of CMR multiparameters over conventional serum examinations for identifying SR. Methods and results: Heart transplantation (HTx) recipients with endomyocardial biopsy and healthy controls were prospectively recruited for CMR assessment. CMR feature tracking was performed to evaluate the left ventricular (LV) global strain in all three directions. The last serum examinations including N-terminal pro-brain natriuretic peptide (NT-proBNP) before anti-rejection therapy were recorded. Participants were divided into three groups: control, SR [acute cellular rejection grade ≥ 2R and/or antibody-mediated rejection (AMR) grade ≥ pAMR1], and NSR (non-SR). Finally, 30 controls (43.3 ± 13.6 years, 26 males) and 51 HTx recipients comprising 23 SRs (48.6 ± 12.6 years, 24 males) and 28 NSRs (42.7 ± 14.9 years, 16 males) were enrolled for analysis. Compared with NSRs, SRs showed elevated NT-proBNP (7797.0 ± 7527.6 pg/mL vs. 3334.6 ± 5935.3 pg/mL, P < 0.001), worse LV global longitudinal strain (GLS) (−9.7 ± 3.1% vs. −13.1 ± 2.9%, P < 0.001), and increased native T1 (1384 ± 80.1 ms vs. 1321 ± 69.9 ms, P < 0.001) and T2 values (50.9 ± 2.7 ms vs. 45.7 ± 4.3 ms, P < 0.001). In multivariable analysis, LVGLS (OR = 0.76, 95% CI, 0.59–0.98, P = 0.03) and T2 value (OR = 1.35, 95% CI, 1.10–1.65, P = 0.01) were independently associated with SR after NT-proBNP adjustment. Furthermore, the likelihood ratio test showed LVGLS (P = 0.002) and T2 value (P < 0.001) had incremental value over NT-proBNP for identifying SR. Conclusion: LVGLS and T2 value were independently associated with SR, providing incremental value for non-invasive identification of significant rejection in HTx recipients.